List of Studies ( Metabolite:Methacholine)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
---|---|---|---|---|---|---|---|
ST003790 | AN006231 | Fecal metabolomics of B16-OVA tumor-bearing mice fed chow or low and high fiber purified diets and treated with isotype control or anti-PD-1 antibody | Feces | Mouse | Cancer | Princeton University | LC-MS |
ST003789 | AN006229 | Serum metabolomics of B16-OVA tumor-bearing mice fed chow or low and high fiber purified diets and treated with isotype control or anti-PD-1 antibody | Blood | Mouse | Cancer | Princeton University | LC-MS |
ST003778 | AN006206 | Human to mouse microbiota transfer model demonstrates disease-modifying effects of the short-chain fatty acid biotherapy modified microbiota | Feces | Mouse | Diabetes | University of Queensland | LC-MS |
ST003504 | AN005752 | Methionine-SAM metabolism-dependent ubiquinone synthesis is crucial for ROS accumulation in ferroptosis induction | Cultured cells | Human | Cancer | Northeast Normal University | LC-MS |
ST003504 | AN005752 | Methionine-SAM metabolism-dependent ubiquinone synthesis is crucial for ROS accumulation in ferroptosis induction | Cultured cells | Human | Cardiomyopathy | Northeast Normal University | LC-MS |
ST003053 | AN005006 | Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics | Bacterial cells | Staphylococcus aureus | Bacterial infection | Monash University | LC-MS |
ST003036 | AN004977 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 | Bacterial cells | Pseudomonas aeruginosa | Bacterial infection | Monash Institute of Pharmaceutical Sciences | LC-MS |
ST002977 | AN004887 | Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant | Feces | Human | University of Michigan | LC-MS | |
ST002950 | AN004838 | Investigate the impact of feeding time on the hexosamine biosynthetic pathway (HBP) in the mouse liver and heart using targeted metabolomics: biogenic amines | Heart | Mouse | University of California, Davis | LC-MS | |
ST002950 | AN004838 | Investigate the impact of feeding time on the hexosamine biosynthetic pathway (HBP) in the mouse liver and heart using targeted metabolomics: biogenic amines | Liver | Mouse | University of California, Davis | LC-MS | |
ST002926 | AN004798 | Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides fragilis | Stanford University | LC-MS | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides thetaiotaomicron | Stanford University | LC-MS | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides uniformis | Stanford University | LC-MS | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Blautia producta | Stanford University | LC-MS | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium clostridioforme | Stanford University | LC-MS | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hathewayi | Stanford University | LC-MS | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hylemonae | Stanford University | LC-MS | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium scindens | Stanford University | LC-MS | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium symbiosum | Stanford University | LC-MS | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecalis | Stanford University | LC-MS | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecium | Stanford University | LC-MS | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus hirae | Stanford University | LC-MS | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Escherichia fergusonii | Stanford University | LC-MS | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Flavonifractor plautii | Stanford University | LC-MS | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Parabacteroides distasonis | Stanford University | LC-MS | |
ST002747 | AN004454 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Human | CZ Biohub | LC-MS | |
ST002747 | AN004454 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Rickettsia parkeri | CZ Biohub | LC-MS | |
ST002513 | AN004138 | Gnotobiotic mice: Metabolites in serum of germ-free mice colonized with strains of gut bacterium Eggerthella lenta | Blood | Mouse | University of California, San Francisco | LC-MS | |
ST002512 | AN004136 | Gnotobiotic mice: Metabolites in intestinal contents of germ-free mice colonized with strains of gut bacterium Eggerthella lenta | Intestine | Mouse | University of California, San Francisco | LC-MS | |
ST002493 | AN004086 | Composition of raw plant-based food items Pilot Study | Plant | Apple | Northeastern University; Massachusets Institute of Technology | LC-MS | |
ST002493 | AN004086 | Composition of raw plant-based food items Pilot Study | Plant | Basil | Northeastern University; Massachusets Institute of Technology | LC-MS | |
ST002493 | AN004086 | Composition of raw plant-based food items Pilot Study | Plant | Garlic | Northeastern University; Massachusets Institute of Technology | LC-MS | |
ST002493 | AN004086 | Composition of raw plant-based food items Pilot Study | Plant | Lettuce | Northeastern University; Massachusets Institute of Technology | LC-MS | |
ST002493 | AN004086 | Composition of raw plant-based food items Pilot Study | Plant | Strawberry | Northeastern University; Massachusets Institute of Technology | LC-MS | |
ST002493 | AN004086 | Composition of raw plant-based food items Pilot Study | Plant | Tomato | Northeastern University; Massachusets Institute of Technology | LC-MS | |
ST002477 | AN004046 | Neutrophil metabolomics in COVID-19 | Neutrophils | Human | COVID-19 | UT Southwestern Medical Center | LC-MS |
ST002438 | AN003974 | Ozone alters glycosphingolipid metabolism and exacerbates characteristics of asthma in mice | Lung | Mouse | Asthma | University of California, Davis | LC-MS |
ST002309 | AN003771 | Targeting malaria parasites with novel derivatives of azithromycin | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST002263 | AN003696 | Intermittent fasting induces rapid hepatocyte proliferation to maintain the hepatostat | Liver | Mouse | Stanford University | LC-MS | |
ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
ST002066 | AN003365 | Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer | Lung | Mouse | Cancer | Walter and Eliza Hall Institute of Medical Research | LC-MS |
ST002003 | AN003266 | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 4) | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | Columbia University | LC-MS |
ST001928 | AN003136 | Metabolomics profiles of premenopausal women are different based on O-desmethylangolensin metabotype | Urine | Human | George Mason University | LC-MS | |
ST001888 | AN003057 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
ST001844 | AN002987 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part III) | Blood | Human | Fatty liver disease | University of California, Davis | GC-MS |
ST001844 | AN002987 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part III) | Liver | Human | Fatty liver disease | University of California, Davis | GC-MS |
ST001841 | AN002984 | Metabolomics of lung microdissections reveals region- and sex-specific metabolic effects of acute naphthalene exposure in mice (part II) | Liver | Mouse | Oxidative stress | University of California, Davis | GC-MS |
ST001788 | AN002899 | β-Adrenergic regulation of metabolism in macrophages (part-IV) | Macrophages | Human | Monash University | LC-MS | |
ST001782 | AN002893 | Examining the Identified Differential Metabolites in Other Antipsychotics with a High Fatality Frequency (part IV) | Blood | Mouse | Hebei medical university | LC-MS | |
ST001746 | AN002842 | Examining the Identified Differential Metabolites in Other Antipsychotics with a High Fatality Frequency | Blood | Mouse | Hebei medical university | LC-MS | |
ST001739 | AN002832 | Differential Metabolites and Disturbed Metabolic Pathways Associated with chlorpromazine Poisoning | Blood | Mouse | Hebei medical university | LC-MS | |
ST001637 | AN002675 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
ST001549 | AN002580 | β-Adrenergic regulation of metabolism in macrophages (part-III) | Macrophages | Human | Monash University | LC-MS | |
ST001548 | AN002578 | β-Adrenergic regulation of metabolism in macrophages (part-II) | Macrophages | Human | Monash University | LC-MS | |
ST001547 | AN002576 | β-Adrenergic regulation of metabolism in macrophages | Macrophages | Human | Monash University | LC-MS | |
ST001413 | AN002363 | Metabolomic and Transcriptomic Signatures of Prenatal Excessive Methionine in Mice | Brain | Mouse | University of California, Irvine | LC-MS | |
ST001324 | AN002202 | Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress | Hepatopancreas | Pacific Abalone | Institute of Oceanology, Chinese Academy of Sciences | LC-MS | |
ST001315 | AN002189 | Retargeting azithromycin-like compounds as antimalarials with dual modality | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST001304 | AN002172 | Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii | Fibroblast cells | Toxoplasma gondii | Parasitic infection | Monash University | LC-MS |
ST001205 | AN002006 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
ST001205 | AN002006 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST001204 | AN002005 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
ST001204 | AN002005 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST001202 | AN002000 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
ST001202 | AN002000 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST001201 | AN001998 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
ST001201 | AN001998 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST001175 | AN001950 | Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST001122 | AN001847 | Identification of urine metabolites in patients with interstitial cystitis using untargeted metabolomics (part II) | Urine | Human | Interstitial cystitis | University of California, Davis | LC-MS |
ST001033 | AN001694 | Determination of mode of action of anti-malalrial drugs using untargeted metabolomics | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST000546 | AN000832 | Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium | Cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST000414 | AN000655 | Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action | Cells | Plasmodium falciparum | Malaria | Monash Institute of Pharmaceutical Sciences | LC-MS |